Abstract
Dramatic, overnight cost increases of important orphan and generic medications have recently come under public and government scrutiny. We highlight the case of aerosolized ribavirin, an important antiviral agent in hematopoietic stem cell transplantation which, because of substantial price increases, may now cost more than the transplant procedure itself.
Original language | English (US) |
---|---|
Pages (from-to) | 634-636 |
Number of pages | 3 |
Journal | Transplant Infectious Disease |
Volume | 18 |
Issue number | 4 |
DOIs | |
State | Published - Aug 1 2016 |
Keywords
- average wholesale price
- cost
- hematologic malignancy
- hematopoietic stem cell transplantation
- pediatrics
- respiratory syncytial virus
ASJC Scopus subject areas
- Infectious Diseases
- Transplantation